{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:43:50Z","timestamp":1780357430186,"version":"3.54.1"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm Regener"],"DOI":"10.1186\/s41232-026-00423-7","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:06:09Z","timestamp":1778123169000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Th9 cells at the intersection of IBD and colorectal cancer: a context-dependent factor in carcinogenesis"],"prefix":"10.1186","volume":"46","author":[{"given":"Niloufar","family":"Afrough","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negin","family":"Yadolahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Khodadadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4925-2439","authenticated-orcid":false,"given":"Mojtaba","family":"Shohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"issue":"6","key":"423_CR1","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1365-2036.2007.03241.x","volume":"25","author":"T Thomas","year":"2007","unstructured":"Thomas T, Abrams KA, Robinson RJ, Mayberry JF. Meta\u2010analysis: cancer risk of low\u2010grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther. 2007;25(6):657\u201368.","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"423_CR2","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1053\/j.gastro.2010.02.007","volume":"138","author":"S S\u00f6derlund","year":"2010","unstructured":"S\u00f6derlund S, Granath F, Brostr\u00f6m O, Karl\u00e9n P, L\u00f6fberg R, Ekbom A, et al. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males. Gastroenterology. 2010;138(5):1697\u2013703.","journal-title":"Gastroenterology"},{"issue":"22","key":"423_CR3","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.3748\/wjg.v23.i22.4039","volume":"23","author":"M Matusiewicz","year":"2017","unstructured":"Matusiewicz M, Neubauer K, Bednarz-Misa I, Gorska S, Krzystek-Korpacka M. Systemic interleukin-9 in inflammatory bowel disease: association with mucosal healing in ulcerative colitis. World J Gastroenterol. 2017;23(22):4039.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"423_CR4","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1159\/000341692","volume":"30","author":"S Foersch","year":"2012","unstructured":"Foersch S, Waldner MJ, Neurath MF. Colitis and colorectal cancer. Dig Dis. 2012;30(5):469\u201376.","journal-title":"Dig Dis"},{"issue":"2","key":"423_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.canlet.2013.07.032","volume":"345","author":"G Rogler","year":"2014","unstructured":"Rogler G. Chronic ulcerative colitis and colorectal cancer. Cancer Lett. 2014;345(2):235\u201341.","journal-title":"Cancer Lett"},{"issue":"1","key":"423_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4049\/jimmunol.2300094","volume":"211","author":"A Pajulas","year":"2023","unstructured":"Pajulas A, Zhang J, Kaplan MH. The world according to IL-9. J Immunol. 2023;211(1):7\u201314.","journal-title":"J Immunol"},{"key":"423_CR7","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3389\/fimmu.2018.01139","volume":"9","author":"SP Vyas","year":"2018","unstructured":"Vyas SP, Goswami R. A decade of Th9 cells: role of Th9 cells in inflammatory bowel disease. Front Immunol. 2018;9:1139.","journal-title":"Front Immunol"},{"key":"423_CR8","doi-asserted-by":"crossref","unstructured":"Elyaman W, Khoury SJ. Th9 cells in the pathogenesis of EAE and multiple sclerosis. In: Seminars in immunopathology. Springer; 2017. p. 79\u201387.","DOI":"10.1007\/s00281-016-0604-y"},{"issue":"2","key":"423_CR9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/JLB.MR0318-097R","volume":"105","author":"D Chraa","year":"2019","unstructured":"Chraa D, Naim A, Olive D, Badou A. T lymphocyte subsets in cancer immunity: friends or foes. J Leukoc Biol. 2019;105(2):243\u201355.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"423_CR10","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1038\/s41467-019-10889-4","volume":"10","author":"Y Shen","year":"2019","unstructured":"Shen Y, Song Z, Lu X, Ma Z, Lu C, Zhang B, et al. Fas signaling-mediated TH9 cell differentiation favors bowel inflammation and antitumor functions. Nat Commun. 2019;10(1):2924.","journal-title":"Nat Commun"},{"issue":"1","key":"423_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12964-020-00538-5","volume":"18","author":"J Wan","year":"2020","unstructured":"Wan J, Wu Y, Ji X, Huang L, Cai W, Su Z, et al. IL-9 and IL-9-producing cells in tumor immunity. Cell Commun Signal. 2020;18(1):50.","journal-title":"Cell Commun Signal"},{"issue":"6","key":"423_CR12","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1053\/j.gastro.2021.08.047","volume":"161","author":"WT Kuo","year":"2021","unstructured":"Kuo WT, Zuo L, Odenwald MA, Madha S, Singh G, Gurniak CB, et al. The tight junction protein ZO-1 is dispensable for barrier function but critical for effective mucosal repair. Gastroenterology. 2021;161(6):1924\u201339.","journal-title":"Gastroenterology"},{"key":"423_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.682614","volume":"12","author":"S \u010cu\u017ei\u0107","year":"2021","unstructured":"\u010cu\u017ei\u0107 S, Antoli\u0107 M, Ognjenovi\u0107 A, Stupin-Polan\u010dec D, Petrini\u0107 Grba A, Hrva\u010di\u0107 B, et al. Claudins: beyond tight junctions in human IBD and murine models. Front Pharmacol. 2021;12:682614.","journal-title":"Front Pharmacol"},{"issue":"12","key":"423_CR14","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1093\/ecco-jcc\/jjac097","volume":"16","author":"K Gerlach","year":"2022","unstructured":"Gerlach K, Popp V, Wirtz S, Al-Saifi R, Gonzalez Acera M, Atreya R, et al. PU. 1-driven Th9 cells promote colorectal cancer in experimental colitis models through Il-6 effects in intestinal epithelial cells. J Crohns Colitis. 2022;16(12):1893\u2013910.","journal-title":"J Crohns Colitis"},{"issue":"12","key":"423_CR15","first-page":"22529","volume":"8","author":"Y Ye","year":"2015","unstructured":"Ye Y, Pang Z, Chen W, Ju S, Zhou C. The epidemiology and risk factors of inflammatory bowel disease. Int J Clin Exp Med. 2015;8(12):22529.","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"423_CR16","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/SLA.0b013e3181e61e69","volume":"252","author":"RP Kiran","year":"2010","unstructured":"Kiran RP, Khoury W, Church JM, Lavery IC, Fazio VW, Remzi FH. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn\u2019s and ulcerative colitis based on three decades of experience. Ann Surg. 2010;252(2):330\u20135.","journal-title":"Ann Surg"},{"key":"423_CR17","doi-asserted-by":"publisher","first-page":"153303381985773","DOI":"10.1177\/1533033819857737","volume":"18","author":"J Wang","year":"2019","unstructured":"Wang J, Sun M, Zhao H, Huang Y, Li D, Mao D, et al. IL-9 exerts antitumor effects in colon cancer and transforms the tumor microenvironment in vivo. Technol Cancer Res Treat. 2019;18:1533033819857737.","journal-title":"Technol Cancer Res Treat"},{"issue":"10","key":"423_CR18","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/intimm\/dxt039","volume":"25","author":"P Zhao","year":"2013","unstructured":"Zhao P, Xiao X, Ghobrial RM, Li XC. IL-9 and Th9 cells: progress and challenges. Int Immunol. 2013;25(10):547\u201351.","journal-title":"Int Immunol"},{"issue":"1","key":"423_CR19","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1084\/jem.169.1.363","volume":"169","author":"J Van Snick","year":"1989","unstructured":"Van Snick J, Goethals A, Renauld JC, Van Roost E, Uyttenhove C, Rubira MR, et al. Cloning and characterization of a cDNA for a new mouse T cell growth factor (P40). J Exp Med. 1989;169(1):363\u20138.","journal-title":"J Exp Med"},{"issue":"3\u20134","key":"423_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3109\/08830189809043001","volume":"16","author":"JB Demoulin","year":"1998","unstructured":"Demoulin JB, Renauld JC. Interleukin 9 and its receptor: an overview of structure and function. Int Rev Immunol. 1998;16(3\u20134):345\u201364.","journal-title":"Int Rev Immunol"},{"issue":"4","key":"423_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/BF00204898","volume":"31","author":"BA Mock","year":"1990","unstructured":"Mock BA, Krall M, Kozak CA, Nesbitt MN, McBride OW, Renauld JC, et al. IL9 maps to mouse chromosome 13 and human chromosome 5. Immunogenetics. 1990;31(4):265\u201370.","journal-title":"Immunogenetics"},{"issue":"12","key":"423_CR22","doi-asserted-by":"publisher","first-page":"5690","DOI":"10.1073\/pnas.89.12.5690","volume":"89","author":"JC Renauld","year":"1992","unstructured":"Renauld JC, Druez C, Kermouni A, HouSSIAU F, Uyttenhove C, Van Roost E, et al. Expression cloning of the murine and human interleukin 9 receptor cDNAs. Proc Natl Acad Sci. 1992;89(12):5690\u20134.","journal-title":"Proc Natl Acad Sci"},{"issue":"5187","key":"423_CR23","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1126\/science.7973658","volume":"266","author":"SM Russell","year":"1994","unstructured":"Russell SM, Johnston JA, Noguchi M, Kawamura M, Bacon CM, Friedmann M, et al. Interaction of IL-2R\u03b2 and \u03b3c chains with Jak1 and Jak3: implications for XSCID and XCID. Science (80- ). 1994;266(5187):1042\u20135.","journal-title":"Science (80- )"},{"issue":"15","key":"423_CR24","doi-asserted-by":"publisher","first-page":"9255","DOI":"10.1074\/jbc.273.15.9255","volume":"273","author":"JH Bauer","year":"1998","unstructured":"Bauer JH, Liu KD, You Y, Lai SY, Goldsmith MA. Heteromerization of the \u03b3c chain with the interleukin-9 receptor \u03b1 subunit leads to STAT activation and prevention of apoptosis. J Biol Chem. 1998;273(15):9255\u201360.","journal-title":"J Biol Chem"},{"issue":"12","key":"423_CR25","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1038\/sj.onc.1206253","volume":"22","author":"JB Demoulin","year":"2003","unstructured":"Demoulin JB, Louahed J, Dumoutier L, Stevens M, Renauld JC. MAP kinase activation by interleukin-9 in lymphoid and mast cell lines. Oncogene. 2003;22(12):1763\u201370.","journal-title":"Oncogene"},{"issue":"9","key":"423_CR26","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.1128\/MCB.16.9.4710","volume":"16","author":"JB Demoulin","year":"1996","unstructured":"Demoulin JB, Uyttenhove C, Van Roost E, Lestr\u00e9 de B, Donckers D, Van Snick J, et al. A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9. Mol Cell Biol. 1996;16(9):4710\u20136.","journal-title":"Mol Cell Biol"},{"issue":"35","key":"423_CR27","doi-asserted-by":"publisher","first-page":"20497","DOI":"10.1074\/jbc.270.35.20497","volume":"270","author":"T Yin","year":"1995","unstructured":"Yin T, Keller SR, Quelle FW, Witthuhn BA, Tsang MLS, Lienhard GE, et al. Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via JAK tyrosine kinases (\u2217). J Biol Chem. 1995;270(35):20497\u2013502.","journal-title":"J Biol Chem"},{"issue":"11","key":"423_CR28","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1002\/eji.1830191130","volume":"19","author":"E Schmitt","year":"1989","unstructured":"Schmitt E, Brandwijk Van R, Snick Van J, Siebold B, R\u00fcde E. TCGFIII\/P40 is produced by naive murine CD4+ T cells but is not a general T cell growth factor. Eur J Immunol. 1989;19(11):2167\u201370.","journal-title":"Eur J Immunol"},{"issue":"18","key":"423_CR29","doi-asserted-by":"publisher","first-page":"6934","DOI":"10.1073\/pnas.85.18.6934","volume":"85","author":"C Uyttenhove","year":"1988","unstructured":"Uyttenhove C, Simpson RJ, Van Snick J. Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity. Proc Natl Acad Sci U S A. 1988;85(18):6934\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"423_CR30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0171-2985(11)80414-6","volume":"189","author":"A Gessner","year":"1993","unstructured":"Gessner A, Blum H, R\u00f6llinghoff M. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. Immunobiology. 1993;189(5):419\u201335.","journal-title":"Immunobiology"},{"issue":"12","key":"423_CR31","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/ni.1659","volume":"9","author":"M Veldhoen","year":"2008","unstructured":"Veldhoen M, Uyttenhove C, Van Snick J, Helmby H, Westendorf A, Buer J, et al. Transforming growth factor-\u03b2 \u2018reprograms\u2019 the differentiation of T helper 2 cells and promotes an interleukin 9\u2013producing subset. Nat Immunol. 2008;9(12):1341\u20136.","journal-title":"Nat Immunol"},{"issue":"12","key":"423_CR32","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1038\/ni.1677","volume":"9","author":"V Dardalhon","year":"2008","unstructured":"Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, Sobel RA, et al. IL-4 inhibits TGF-\u03b2-induced Foxp3+ T cells and together with TGF-\u03b2, generates IL-9+ IL-10+ Foxp3\u2212 effector T cells. Nat Immunol. 2008;9(12):1347\u201355.","journal-title":"Nat Immunol"},{"issue":"4","key":"423_CR33","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.immuni.2013.07.020","volume":"39","author":"P Licona-Lim\u00f3n","year":"2013","unstructured":"Licona-Lim\u00f3n P, Henao-Mejia J, Temann AU, Gagliani N, Licona-Lim\u00f3n I, Ishigame H, et al. Th9 cells drive host immunity against gastrointestinal worm infection. Immunity. 2013;39(4):744\u201357.","journal-title":"Immunity"},{"issue":"6","key":"423_CR34","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/icb.2010.53","volume":"88","author":"MT Wong","year":"2010","unstructured":"Wong MT, Ye JJ, Alonso MN, Landrigan A, Cheung RK, Engleman E, et al. Regulation of human Th9 differentiation by type I interferons and IL-21. Immunol Cell Biol. 2010;88(6):624\u201331.","journal-title":"Immunol Cell Biol"},{"issue":"8","key":"423_CR35","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1084\/jem.20090246","volume":"206","author":"EC Nowak","year":"2009","unstructured":"Nowak EC, Weaver CT, Turner H, Begum-Haque S, Becher B, Schreiner B, et al. IL-9 as a mediator of Th17-driven inflammatory disease. J Exp Med. 2009;206(8):1653\u201360.","journal-title":"J Exp Med"},{"issue":"7106","key":"423_CR36","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/nature05010","volume":"442","author":"LF Lu","year":"2006","unstructured":"Lu LF, Lind EF, Gondek DC, Bennett KA, Gleeson MW, Pino-Lagos K, et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature. 2006;442(7106):997\u20131002.","journal-title":"Nature"},{"issue":"31","key":"423_CR37","doi-asserted-by":"publisher","first-page":"12885","DOI":"10.1073\/pnas.0812530106","volume":"106","author":"W Elyaman","year":"2009","unstructured":"Elyaman W, Bradshaw EM, Uyttenhove C, Dardalhon V, Awasthi A, Imitola J, et al. IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells. Proc Natl Acad Sci. 2009;106(31):12885\u201390.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"423_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4049\/jimmunol.1001183","volume":"186","author":"K Eller","year":"2011","unstructured":"Eller K, Wolf D, Huber JM, Metz M, Mayer G, McKenzie ANJ, et al. IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression. J Immunol. 2011;186(1):83\u201391.","journal-title":"J Immunol"},{"issue":"1","key":"423_CR39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4049\/jimmunol.1000356","volume":"185","author":"G Beriou","year":"2010","unstructured":"Beriou G, Bradshaw EM, Lozano E, Costantino CM, Hastings WD, Orban T, et al. TGF-\u03b2 induces IL-9 production from human Th17 cells. J Immunol. 2010;185(1):46\u201354.","journal-title":"J Immunol"},{"issue":"8","key":"423_CR40","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/ni.3788","volume":"18","author":"Y Wang","year":"2017","unstructured":"Wang Y, Shi J, Yan J, Xiao Z, Hou X, Lu P, et al. Germinal-center development of memory B cells driven by IL-9 from follicular helper T cells. Nat Immunol. 2017;18(8):921\u201330.","journal-title":"Nat Immunol"},{"issue":"4","key":"423_CR41","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.immuni.2012.08.015","volume":"37","author":"J Mj\u00f6sberg","year":"2012","unstructured":"Mj\u00f6sberg J, Bernink J, Golebski K, Karrich JJ, Peters CP, Blom B, et al. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity. 2012;37(4):649\u201359.","journal-title":"Immunity"},{"issue":"1","key":"423_CR42","doi-asserted-by":"publisher","first-page":"14017","DOI":"10.1038\/ncomms14017","volume":"8","author":"S Moretti","year":"2017","unstructured":"Moretti S, Renga G, Oikonomou V, Galosi C, Pariano M, Iannitti RG, et al. A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis. Nat Commun. 2017;8(1):14017.","journal-title":"Nat Commun"},{"issue":"11","key":"423_CR43","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/ni.2133","volume":"12","author":"C Wilhelm","year":"2011","unstructured":"Wilhelm C, Hirota K, Stieglitz B, Van Snick J, Tolaini M, Lahl K, et al. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol. 2011;12(11):1071\u20137.","journal-title":"Nat Immunol"},{"issue":"4","key":"423_CR44","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.immuni.2015.08.020","volume":"43","author":"CY Chen","year":"2015","unstructured":"Chen CY, Lee JB, Liu B, Ohta S, Wang PY, Kartashov AV, et al. Induction of interleukin-9-producing mucosal mast cells promotes susceptibility to IgE-mediated experimental food allergy. Immunity. 2015;43(4):788\u2013802.","journal-title":"Immunity"},{"issue":"11","key":"423_CR45","doi-asserted-by":"publisher","first-page":"5549","DOI":"10.4049\/jimmunol.164.11.5549","volume":"164","author":"M Stassen","year":"2000","unstructured":"Stassen M, Arnold M, H\u00fcltner L, M\u00fcller C, Neud\u00f6rfl C, Reineke T, et al. Murine bone marrow-derived mast cells as potent producers of IL-9: costimulatory function of IL-10 and kit ligand in the presence of IL-1. J Immunol. 2000;164(11):5549\u201355.","journal-title":"J Immunol"},{"issue":"8","key":"423_CR46","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.4373","volume":"23","author":"S Rauber","year":"2017","unstructured":"Rauber S, Luber M, Weber S, Maul L, Soare A, Wohlfahrt T, et al. Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells. Nat Med. 2017;23(8):938\u201344.","journal-title":"Nat Med"},{"key":"423_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.106019","volume":"78","author":"C Wang","year":"2020","unstructured":"Wang C, Lu Y, Chen L, Gao T, Yang Q, Zhu C, et al. Th9 cells are subjected to PD-1\/PD-L1-mediated inhibition and are capable of promoting CD8 T cell expansion through IL-9R in colorectal cancer. Int Immunopharmacol. 2020;78:106019.","journal-title":"Int Immunopharmacol"},{"key":"423_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2019.105576","volume":"115","author":"P Ding","year":"2019","unstructured":"Ding P, Zhu R, Cai B, Zhang J, Bu Q, Sun DW. IL-9-producing CD8+ T cells represent a distinctive subset with different transcriptional characteristics from conventional CD8+ T cells, and partially infiltrate breast tumors. Int J Biochem Cell Biol. 2019;115:105576.","journal-title":"Int J Biochem Cell Biol"},{"issue":"9","key":"423_CR49","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s41590-018-0177-0","volume":"19","author":"S Takatsuka","year":"2018","unstructured":"Takatsuka S, Yamada H, Haniuda K, Saruwatari H, Ichihashi M, Renauld JC, et al. IL-9 receptor signaling in memory B cells regulates humoral recall responses. Nat Immunol. 2018;19(9):1025\u201334.","journal-title":"Nat Immunol"},{"issue":"7","key":"423_CR50","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/eji.1830230743","volume":"23","author":"B Dugas","year":"1993","unstructured":"Dugas B, Renauld JC, P\u00e8ne J, Bonnefoy JY, Peti-Fr\u00e8re C, Braquet P, et al. Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol. 1993;23(7):1687\u201392.","journal-title":"Eur J Immunol"},{"issue":"9","key":"423_CR51","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1084\/jem.189.9.1413","volume":"189","author":"A Vink","year":"1999","unstructured":"Vink A, Warnier G, Brombacher F, Renauld JC. Interleukin 9\u2013induced in vivo expansion of the B-1 lymphocyte population. J Exp Med. 1999;189(9):1413\u201323.","journal-title":"J Exp Med"},{"issue":"5","key":"423_CR52","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.jaci.2007.08.022","volume":"120","author":"LM Fawaz","year":"2007","unstructured":"Fawaz LM, Sharif-Askari E, Hajoui O, Soussi-Gounni A, Hamid Q, Mazer BD. Expression of IL-9 receptor \u03b1 chain on human germinal center B cells modulates IgE secretion. J Allergy Clin Immunol. 2007;120(5):1208\u201315.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"423_CR53","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1183\/09031936.02.00005402","volume":"20","author":"C Pilette","year":"2002","unstructured":"Pilette C, Ouadrhiri Y, Van Snick J, Renauld JC, Staquet P, Vaerman JP, et al. Oxidative burst in lipopolysaccharide-activated human alveolar macrophages is inhibited by interleukin-9. Eur Respir J. 2002;20(5):1198\u2013205.","journal-title":"Eur Respir J"},{"issue":"6","key":"423_CR54","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.4049\/jimmunol.126.6.2365","volume":"126","author":"KJ Johnson","year":"1981","unstructured":"Johnson KJ, Ward PA. Role of oxygen metabolites in immune complex injury of lung. J Immunol. 1981;126(6):2365\u20139.","journal-title":"J Immunol"},{"issue":"8","key":"423_CR55","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.4049\/jimmunol.168.8.4103","volume":"168","author":"C Pilette","year":"2002","unstructured":"Pilette C, Ouadrhiri Y, Van Snick J, Renauld JC, Staquet P, Vaerman JP, et al. IL-9 inhibits oxidative burst and TNF-\u03b1 release in lipopolysaccharide-stimulated human monocytes through TGF-\u03b2. J Immunol. 2002;168(8):4103\u201311.","journal-title":"J Immunol"},{"issue":"5","key":"423_CR56","first-page":"479","volume":"43","author":"SM Park","year":"2020","unstructured":"Park SM, Lee JO, Lee H, Kim YS. Interleukin-9 inhibits lung metastasis of melanoma through stimulating anti-tumor M1 macrophages. Mol Cells. 2020;43(5):479\u201390.","journal-title":"Mol Cells"},{"issue":"4","key":"423_CR57","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.4049\/jimmunol.166.4.2768","volume":"166","author":"SG Abdelilah","year":"2001","unstructured":"Abdelilah SG, Latifa K, Esra N, Cameron L, Bouchaib L, Nicolaides NC, et al. Functional expression of IL-9 receptor by human neutrophils from asthmatic donors: role in IL-8 release. J Immunol. 2001;166(4):2768\u201374.","journal-title":"J Immunol"},{"issue":"6","key":"423_CR58","first-page":"2163","volume":"96","author":"AS Gounni","year":"2000","unstructured":"Gounni AS, Gregory B, Nutku E, Aris F, Latifa K, Minshall E, et al. Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils. Blood, J Am Soc Hematol. 2000;96(6):2163\u201371.","journal-title":"Blood, J Am Soc Hematol"},{"issue":"4","key":"423_CR59","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.4049\/jimmunol.173.4.2771","volume":"173","author":"AS Gounni","year":"2004","unstructured":"Gounni AS, Hamid Q, Rahman SM, Hoeck J, Yang J, Shan L. IL-9-mediated induction of eotaxin1\/CCL11 in human airway smooth muscle cells. J Immunol. 2004;173(4):2771\u20139.","journal-title":"J Immunol"},{"issue":"7","key":"423_CR60","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ni.2920","volume":"15","author":"K Gerlach","year":"2014","unstructured":"Gerlach K, Hwang Y, Nikolaev A, Atreya R, Dornhoff H, Steiner S, et al. TH9 cells that express the transcription factor PU. 1 drive T cell\u2013mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat Immunol. 2014;15(7):676\u201386.","journal-title":"Nat Immunol"},{"issue":"6","key":"423_CR61","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1165\/ajrcmb.22.6.3927","volume":"22","author":"J Louahed","year":"2000","unstructured":"Louahed J, Toda M, Jen J, Hamid Q, Renauld JC, Levitt RC, et al. Interleukin-9 upregulates mucus expression in the airways. Am J Respir Cell Mol Biol. 2000;22(6):649\u201356.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"7","key":"423_CR62","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.4049\/jimmunol.1800823","volume":"202","author":"S Das","year":"2019","unstructured":"Das S, Srinivasan S, Srivastava A, Kumar S, Das G, Das S, et al. Differential influence of IL-9 and IL-17 on actin cytoskeleton regulates the migration potential of human keratinocytes. J Immunol. 2019;202(7):1949\u201361.","journal-title":"J Immunol"},{"issue":"7","key":"423_CR63","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1038\/jid.2014.61","volume":"134","author":"J Liu","year":"2014","unstructured":"Liu J, Harberts E, Tammaro A, Girardi N, Filler RB, Fishelevich R, et al. IL-9 regulates allergen-specific Th1 responses in allergic contact dermatitis. J Invest Dermatol. 2014;134(7):1903\u201311.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"423_CR64","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jdermsci.2015.03.004","volume":"78","author":"CH Hong","year":"2015","unstructured":"Hong CH, Chang KL, Wang HJ, Yu HS, Lee CH. IL-9 induces IL-8 production via STIM1 activation and ERK phosphorylation in epidermal keratinocytes: a plausible mechanism of IL-9R in atopic dermatitis. J Dermatol Sci. 2015;78(3):206\u201314.","journal-title":"J Dermatol Sci"},{"issue":"1","key":"423_CR65","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/cei.12198","volume":"175","author":"L Ma","year":"2014","unstructured":"Ma L, Xue HB, Guan XH, Shu CM, Zhang JH, Yu J. Possible pathogenic role of T helper type 9 cells and interleukin (IL)-9 in atopic dermatitis. Clin Exp Immunol. 2014;175(1):25\u201331.","journal-title":"Clin Exp Immunol"},{"key":"423_CR66","doi-asserted-by":"crossref","unstructured":"Niehues H, Smits JPH, Rodijk-Olthuis D, Schalkwijk J, van den Bogaard EHJ. Keratinocyte proliferation and differentiation on IL-9 stimulation: an explorative in vitro study. 2017.","DOI":"10.2340\/00015555-2643"},{"issue":"12","key":"423_CR67","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/nri954","volume":"2","author":"KM Murphy","year":"2002","unstructured":"Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol. 2002;2(12):933\u201344.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"423_CR68","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/ni808","volume":"3","author":"O Avni","year":"2002","unstructured":"Avni O, Lee D, Macian F, Szabo SJ, Glimcher LH, Rao A. TH cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat Immunol. 2002;3(7):643\u201351.","journal-title":"Nat Immunol"},{"issue":"2","key":"423_CR69","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S1074-7613(00)80605-6","volume":"9","author":"JJ Bird","year":"1998","unstructured":"Bird JJ, Brown DR, Mullen AC, Moskowitz NH, Mahowald MA, Sider JR, et al. Helper T cell differentiation is controlled by the cell cycle. Immunity. 1998;9(2):229\u201337.","journal-title":"Immunity"},{"issue":"6","key":"423_CR70","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S1074-7613(00)80642-1","volume":"9","author":"S Agarwal","year":"1998","unstructured":"Agarwal S, Rao A. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation. Immunity. 1998;9(6):765\u201375.","journal-title":"Immunity"},{"issue":"6","key":"423_CR71","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/ni.1867","volume":"11","author":"HC Chang","year":"2010","unstructured":"Chang HC, Sehra S, Goswami R, Yao W, Yu Q, Stritesky GL, et al. The transcription factor PU. 1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol. 2010;11(6):527\u201334.","journal-title":"Nat Immunol"},{"issue":"4","key":"423_CR72","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.it.2011.01.006","volume":"32","author":"NB Perumal","year":"2011","unstructured":"Perumal NB, Kaplan MH. Regulating Il9 transcription in T helper cells. Trends Immunol. 2011;32(4):146\u201350.","journal-title":"Trends Immunol"},{"issue":"3","key":"423_CR73","doi-asserted-by":"publisher","first-page":"968","DOI":"10.4049\/jimmunol.1102840","volume":"188","author":"R Goswami","year":"2012","unstructured":"Goswami R, Jabeen R, Yagi R, Pham D, Zhu J, Goenka S, et al. STAT6-dependent regulation of Th9 development. J Immunol. 2012;188(3):968\u201375.","journal-title":"J Immunol"},{"issue":"11","key":"423_CR74","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1172\/JCI69489","volume":"123","author":"R Jabeen","year":"2013","unstructured":"Jabeen R, Goswami R, Awe O, Kulkarni A, Nguyen ET, Attenasio A, et al. Th9 cell development requires a BATF-regulated transcriptional network. J Clin Invest. 2013;123(11):4641\u201353.","journal-title":"J Clin Invest"},{"issue":"1","key":"423_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10857","volume":"7","author":"J Gomez-Rodriguez","year":"2016","unstructured":"Gomez-Rodriguez J, Meylan F, Handon R, Hayes ET, Anderson SM, Kirby MR, et al. Itk is required for Th9 differentiation via TCR-mediated induction of IL-2 and IRF4. Nat Commun. 2016;7(1):10857.","journal-title":"Nat Commun"},{"issue":"9","key":"423_CR76","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.4049\/jimmunol.153.9.3989","volume":"153","author":"E Schmitt","year":"1994","unstructured":"Schmitt E, Germann T, Goedert S, Hoehn P, Huels C, Koelsch S, et al. IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma. J Immunol. 1994;153(9):3989\u201396.","journal-title":"J Immunol"},{"issue":"8","key":"423_CR77","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/ni.2925","volume":"15","author":"F V\u00e9gran","year":"2014","unstructured":"V\u00e9gran F, Berger H, Boidot R, Mignot G, Bruchard M, Dosset M, et al. The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells. Nat Immunol. 2014;15(8):758\u201366.","journal-title":"Nat Immunol"},{"issue":"5","key":"423_CR78","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.4049\/jimmunol.1301276","volume":"191","author":"T Tamiya","year":"2013","unstructured":"Tamiya T, Ichiyama K, Kotani H, Fukaya T, Sekiya T, Shichita T, et al. Smad2\/3 and IRF4 play a cooperative role in IL-9\u2013producing T cell induction. J Immunol. 2013;191(5):2360\u201371.","journal-title":"J Immunol"},{"issue":"10","key":"423_CR79","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.4049\/jimmunol.1300433","volume":"191","author":"A Wang","year":"2013","unstructured":"Wang A, Pan D, Lee YH, Martinez GJ, Feng X, Dong C. Cutting edge: Smad2 and Smad4 regulate TGF-\u03b2\u2013mediated Il9 gene expression via EZH2 displacement. J Immunol. 2013;191(10):4908\u201312.","journal-title":"J Immunol"},{"issue":"4","key":"423_CR80","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.immuni.2012.01.020","volume":"36","author":"W Elyaman","year":"2012","unstructured":"Elyaman W, Bassil R, Bradshaw EM, Orent W, Lahoud Y, Zhu B, et al. Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9-producing T cells. Immunity. 2012;36(4):623\u201334.","journal-title":"Immunity"},{"issue":"10","key":"423_CR81","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1038\/ni.3252","volume":"16","author":"H Nakatsukasa","year":"2015","unstructured":"Nakatsukasa H, Zhang D, Maruyama T, Chen H, Cui K, Ishikawa M, et al. The DNA-binding inhibitor Id3 regulates IL-9 production in CD4+ T cells. Nat Immunol. 2015;16(10):1077\u201384.","journal-title":"Nat Immunol"},{"issue":"6","key":"423_CR82","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.immuni.2016.05.009","volume":"44","author":"Y Wang","year":"2016","unstructured":"Wang Y, Bi Y, Chen X, Li C, Li Y, Zhang Z, et al. Histone deacetylase SIRT1 negatively regulates the differentiation of interleukin-9-producing CD4+ T cells. Immunity. 2016;44(6):1337\u201349.","journal-title":"Immunity"},{"issue":"1","key":"423_CR83","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/imm.12631","volume":"149","author":"Y Singh","year":"2016","unstructured":"Singh Y, Garden OA, Lang F, Cobb BS. Micro RNA s regulate T\u2010cell production of interleukin\u20109 and identify hypoxia\u2010inducible factor\u20102\u03b1 as an important regulator of T helper 9 and regulatory T\u2010cell differentiation. Immunology. 2016;149(1):74\u201386.","journal-title":"Immunology"},{"issue":"6","key":"423_CR84","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.4049\/jimmunol.1201496","volume":"189","author":"R Goswami","year":"2012","unstructured":"Goswami R, Kaplan MH. Gcn5 is required for PU. 1-dependent IL-9 induction in Th9 cells. J Immunol. 2012;189(6):3026\u201333.","journal-title":"J Immunol"},{"key":"423_CR85","doi-asserted-by":"crossref","unstructured":"Koh B, Hufford MM, Pham D, Olson MR, Wu T, Jabeen R, et al. The ETS family transcription factors Etv5 and PU. 1 function in parallel to promote Th9 cell development. J Immunol. 2016;197(6):2465\u201372.","DOI":"10.4049\/jimmunol.1502383"},{"issue":"2","key":"423_CR86","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.immuni.2010.07.014","volume":"33","author":"V Staudt","year":"2010","unstructured":"Staudt V, Bothur E, Klein M, Lingnau K, Reuter S, Grebe N, et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity. 2010;33(2):192\u2013202.","journal-title":"Immunity"},{"issue":"19","key":"423_CR87","doi-asserted-by":"publisher","first-page":"15445","DOI":"10.1074\/jbc.M112.340356","volume":"287","author":"A Jash","year":"2012","unstructured":"Jash A, Sahoo A, Kim GC, Chae CS, Hwang JS, Kim JE, et al. Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-\u03baB (NF-\u03baB)-mediated interleukin-9 (IL-9) transactivation. J Biol Chem. 2012;287(19):15445\u201357.","journal-title":"J Biol Chem"},{"issue":"9","key":"423_CR88","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/nm.3922","volume":"21","author":"IK Kim","year":"2015","unstructured":"Kim IK, Kim BS, Koh CH, Seok JW, Park JS, Shin KS, et al. Glucocorticoid-induced tumor necrosis factor receptor\u2013related protein co-stimulation facilitates tumor regression by inducing IL-9\u2013producing helper T cells. Nat Med. 2015;21(9):1010\u20137.","journal-title":"Nat Med"},{"issue":"1","key":"423_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9266","volume":"6","author":"X Xiao","year":"2015","unstructured":"Xiao X, Shi X, Fan Y, Zhang X, Wu M, Lan P, et al. GITR subverts Foxp3+ Tregs to boost Th9 immunity through regulation of histone acetylation. Nat Commun. 2015;6(1):8266.","journal-title":"Nat Commun"},{"issue":"10","key":"423_CR90","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/ni.2390","volume":"13","author":"X Xiao","year":"2012","unstructured":"Xiao X, Balasubramanian S, Liu W, Chu X, Wang H, Taparowsky EJ, et al. OX40 signaling favors the induction of TH9 cells and airway inflammation. Nat Immunol. 2012;13(10):981\u201390.","journal-title":"Nat Immunol"},{"issue":"11","key":"423_CR91","doi-asserted-by":"publisher","first-page":"6795","DOI":"10.4049\/jimmunol.1001676","volume":"185","author":"C Tan","year":"2010","unstructured":"Tan C, Aziz MK, Lovaas JD, Vistica BP, Shi G, Wawrousek EF, et al. Antigen-specific Th9 cells exhibit uniqueness in their kinetics of cytokine production and short retention at the inflammatory site. J Immunol. 2010;185(11):6795\u2013801.","journal-title":"J Immunol"},{"issue":"2","key":"423_CR92","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.immuni.2013.01.007","volume":"38","author":"W Yao","year":"2013","unstructured":"Yao W, Zhang Y, Jabeen R, Nguyen ET, Wilkes DS, Tepper RS, et al. Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity. 2013;38(2):360\u201372.","journal-title":"Immunity"},{"issue":"4","key":"423_CR93","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1080\/08830185.2018.1457659","volume":"37","author":"M Shohan","year":"2018","unstructured":"Shohan M, Elahi S, Shirzad H, Rafieian-Kopaei M, Bagheri N, Soltani E. Th9 cells: probable players in ulcerative colitis pathogenesis. Int Rev Immunol. 2018;37(4):192\u2013205.","journal-title":"Int Rev Immunol"},{"issue":"5","key":"423_CR94","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1136\/gutjnl-2013-305947","volume":"64","author":"N Nalleweg","year":"2015","unstructured":"Nalleweg N, Chiriac MT, Podstawa E, Lehmann C, Rau TT, Atreya R, et al. IL-9 and its receptor are predominantly involved in the pathogenesis of UC. Gut. 2015;64(5):743\u201355.","journal-title":"Gut"},{"issue":"4","key":"423_CR95","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1177\/0394632015600535","volume":"28","author":"C Defendenti","year":"2015","unstructured":"Defendenti C, Sarzi-Puttini P, Saibeni S, Bollani S, Bruno S, Almasio PL, et al. Significance of serum Il-9 levels in inflammatory bowel disease. Int J Immunopathol Pharmacol. 2015;28(4):569\u201375.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"3","key":"423_CR96","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00428-012-1195-1","volume":"460","author":"P Das","year":"2012","unstructured":"Das P, Goswami P, Das TK, Nag T, Sreenivas V, Ahuja V, et al. Comparative tight junction protein expressions in colonic Crohn\u2019s disease, ulcerative colitis, and tuberculosis: a new perspective. Virchows Arch. 2012;460(3):261\u201370.","journal-title":"Virchows Arch"},{"key":"423_CR97","doi-asserted-by":"crossref","unstructured":"Neurath MF. New insights into Th9 cells in inflammatory bowel diseases. In: Seminars in Immunology. Elsevier; 2026. p. 102013.","DOI":"10.1016\/j.smim.2025.102013"},{"issue":"2","key":"423_CR98","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.advms.2018.03.002","volume":"63","author":"K Matusiewicz","year":"2018","unstructured":"Matusiewicz K, Iwa\u0144czak B, Matusiewicz M. Th9 lymphocytes and functions of interleukin 9 with the focus on IBD pathology. Adv Med Sci. 2018;63(2):278\u201384.","journal-title":"Adv Med Sci"},{"issue":"4","key":"423_CR99","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.bbrc.2015.11.057","volume":"468","author":"A Yuan","year":"2015","unstructured":"Yuan A, Yang H, Qi H, Cui J, Hua W, Li C, et al. IL-9 antibody injection suppresses the inflammation in colitis mice. Biochem Biophys Res Commun. 2015;468(4):921\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"423_CR100","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20181521","volume":"38","author":"L Tian","year":"2018","unstructured":"Tian L, Li Y, Zhang J, Chang R, Li J, Huo L. IL-9 promotes the pathogenesis of ulcerative colitis through STAT3\/SOCS3 signaling. Biosci Rep. 2018;38(6):BSR20181521.","journal-title":"Biosci Rep"},{"issue":"3","key":"423_CR101","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3892\/etm.2015.2588","volume":"10","author":"Y Huang","year":"2015","unstructured":"Huang Y, Cao Y, Zhang S, Gao F. Association between low expression levels of interleukin-9 and colon cancer progression. Exp Ther Med. 2015;10(3):942\u20136.","journal-title":"Exp Ther Med"},{"issue":"11","key":"423_CR102","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1172\/JCI65459","volume":"122","author":"Y Lu","year":"2012","unstructured":"Lu Y, Hong S, Li H, Park J, Hong B, Wang L, et al. Th9 cells promote antitumor immune responses in vivo. J Clin Invest. 2012;122(11):4160\u201371.","journal-title":"J Clin Invest"},{"key":"423_CR103","doi-asserted-by":"publisher","DOI":"10.4161\/onci.23084","volume":"2","author":"Y Lu","year":"2013","unstructured":"Lu Y, Yi Q. Utilizing TH9 cells as a novel therapeutic strategy for malignancies. Oncoimmunology. 2013;2: e23084 PMID: 23802062.","journal-title":"Oncoimmunology"},{"issue":"8","key":"423_CR104","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/nm.2856","volume":"18","author":"R Purwar","year":"2012","unstructured":"Purwar R, Schlapbach C, Xiao S, Kang HS, Elyaman W, Jiang X, et al. Robust tumor immunity to melanoma mediated by interleukin-9\u2013producing T cells. Nat Med. 2012;18(8):1248\u201353.","journal-title":"Nat Med"},{"issue":"4","key":"423_CR105","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/ijc.30121","volume":"139","author":"A Abdul-Wahid","year":"2016","unstructured":"Abdul-Wahid A, Cydzik M, Prodeus A, Alwash M, Stanojcic M, Thompson M, et al. Induction of antigen-specific TH9 immunity accompanied by mast cell activation blocks tumor cell engraftment. Int J cancer. 2016;139(4):841\u201353.","journal-title":"Int J cancer"},{"issue":"3","key":"423_CR106","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1158\/0008-5472.CAN-14-2748","volume":"75","author":"F V\u00e9gran","year":"2015","unstructured":"V\u00e9gran F, Apetoh L, Ghiringhelli F. Th9 cells: a novel CD4 T-cell subset in the immune war against cancer. Cancer Res. 2015;75(3):475\u20139.","journal-title":"Cancer Res"},{"key":"423_CR107","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.canlet.2021.01.002","volume":"502","author":"J Wan","year":"2021","unstructured":"Wan J, Wu Y, Huang L, Tian Y, Ji X, Abdelaziz MH, et al. ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8+ T cells. Cancer Lett. 2021;502:34\u201343.","journal-title":"Cancer Lett"},{"key":"423_CR108","doi-asserted-by":"publisher","DOI":"10.1177\/11795549241301358","volume":"18","author":"G Cui","year":"2024","unstructured":"Cui G, Yuan A, S\u00f8rbye SW, Florholmen J. Th9 and Th17 cells in human ulcerative colitis-associated dysplastic lesions. Clin Med Insights Oncol. 2024;18:11795549241301358.","journal-title":"Clin Med Insights Oncol"},{"issue":"1","key":"423_CR109","first-page":"175","volume":"17","author":"L Tian","year":"2019","unstructured":"Tian L, Li Y, Chang R, Zhang P, Zhang J, Huo L. Lentiviral vector\u2011mediated IL\u20119 overexpression stimulates cell proliferation by targeting c\u2011myc and Cyclin D1 in colitis\u2011associated cancer. Oncol Lett. 2019;17(1):175\u201382.","journal-title":"Oncol Lett"},{"issue":"1","key":"423_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mucimm.2024.10.003","volume":"18","author":"F Bick","year":"2025","unstructured":"Bick F, Blanchetot C, Lambrecht BN, Schuijs MJ. A reappraisal of IL-9 in inflammation and cancer. Mucosal Immunol. 2025;18(1):1\u201315.","journal-title":"Mucosal Immunol"},{"key":"423_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.573158","volume":"11","author":"E Niccolai","year":"2021","unstructured":"Niccolai E, Russo E, Baldi S, Ricci F, Nannini G, Pedone M, et al. Significant and conflicting correlation of IL-9 with Prevotella and Bacteroides in human colorectal cancer. Front Immunol. 2021;11:573158.","journal-title":"Front Immunol"},{"key":"423_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1672072","volume":"16","author":"S Peesari","year":"2025","unstructured":"Peesari S, McAleer JP. Metabolic regulation of Th9 cell differentiation: insights for IL-9-driven diseases. Front Immunol. 2025;16:1672072.","journal-title":"Front Immunol"}],"updated-by":[{"DOI":"10.1186\/s41232-026-00426-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000}}],"container-title":["Inflammation and Regeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41232-026-00423-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-026-00423-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41232-026-00423-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T08:04:26Z","timestamp":1779869066000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41232-026-00423-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["423"],"URL":"https:\/\/doi.org\/10.1186\/s41232-026-00423-7","relation":{},"ISSN":["1880-8190"],"issn-type":[{"value":"1880-8190","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s41232-026-00426-4","URL":"https:\/\/doi.org\/10.1186\/s41232-026-00426-4","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}